BSM Q1 2026 Earnings Massive EPS Miss Amidst 8586 Surprise Downside MDLZ Q1 2026 Earnings Strong EPS Beat Amidst Cost Discipline ACXP Q1 2026 Earnings Narrowed Loss Surprises as Acurx Advances Lead Candidate Skye Bioscience Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Biotech Challenges CGBD Q1 2026 Earnings Narrow EPS Miss Weighs on Investor Sentiment as Portfolio Remains Resilient SPAI Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Unreported